Tag: Belluscura
In brief: CMS to end CHOPD, Lincare CEO to lead CQRC
June 19, 2024HME News Staff
WASHINGTON – CMS has announced that payments under the Accelerated and Advance Payment (AAP) Program for the Change Healthcare/Optum Payment Disruption (CHOPD) will conclude on July 12, 2024.
Launched in early March, the CHOPD payments were designed to ease cash flow disruptions experienced by some Medicare providers and suppliers, such as hospitals, physicians and pharmacists, due to the unprecedented cyberattack that took health care electronic data interchange Change Healthcare...
Belluscura shares performance update
June 17, 2024HME News Staff
LONDON and PLANO, Texas – Belluscura says sales of the X-PLOR portable oxygen concentrator in the United States were $820,000 in the three months to May 2024. The company says it recorded sales of $450,000 in May alone, its highest recorded monthly sales figure, across both direct-to-consumer and business-to-business channels. Belluscura says testing and validation of its DISCOV-R POC remains on schedule to ship in June. The company plans to initially sell the device through its DTC channel,...
In brief: Rehab Medical hits milestone, JANZ supports medics, Belluscura partners with Sunset
February 14, 2024HME News Staff
INDIANAPOLIS – Rehab Medical now has 100 assistive technology professionals (ATPs), a milestone it recently celebrated at a two-day annual conference in downtown Indianapolis.
“This milestone is a great achievement for us, and we are very proud to celebrate it,” said President Kevin Gearheart. “It is also the first of many milestones we expect to cross. We have an outstanding team, and this is just the beginning.”
Reaching the milestone is instrumental...
Belluscura, Sunset Healthcare partner
February 13, 2024HME News Staff
LONDON and PLANO, Texas – Belluscura's X-PLOR portable oxygen concentrator will be offered to more than 1,600 customers of Chicago-based Sunset Healthcare Solutions under a new distribution partnership. The partnership will also include Belluscura’s DISCOV-R POC in the second quarter, when it becomes available to DME providers. "We welcome the new partnership with Sunset Healthcare Solutions, which will provide over 1,600 health care businesses with access to our innovative products...
Belluscura announces increased offer
January 22, 2024HME News Staff
LONDON and PLANO, Texas – The boards of Belluscura and TMT Acquisition have announced the terms of a recommended share offer to be made by Belluscura for the whole of the issued and to be issued share capital of TMT Acquisition. Having regard to the Belluscura share price in recent weeks, the companies have agreed on an increase in the number of new Belluscura shares to be offered in exchange for TMT acquisition shares. The value of a TMT acquisition share under the offer, based on the closing...
In brief: Senators’ demands, F&P’s new execs, Belluscura’s green light
December 21, 2023HME News Staff
WASHINGTON – A group of senators has asked CMS to collect and publish more Medicare Advantage data to help lawmakers and regulators better understand the impact of these plans.
AAHomecare provided the following analysis of the group's new letter to CMS Administrator Chiquita Brooks-Lasure:
The senators cite “concerning trends” in Medicare Advantage and point to a 2019 HHS OIG study that “found that among requests MA plans denied, 13% of prior...
Belluscura gets green light in China
December 20, 2023HME News Staff
LONDON and PLANO, Texas – Belluscura has received approval from the National Medical Products Administration to distribute the X-PLOR portable oxygen concentrator in China. China is part of the licensed territory covered by the exclusive license agreement with InnoMax Medical Device Technologies announced in August 2023. "We are delighted to have received approval in China which has taken over approximately 10 months,” said Bob Rauker, CEO. “This enables us to launch sales...
In brief: Senators write GAO, CMS reports on spending, Quantum appears at the Met
December 15, 2023HME News Staff
WASHINGTON – U.S. Senate Majority Whip Dick Durbin, D-Ill., and U.S. Sen. Richard Blumenthal, D-Conn., have sent a letter to the Government Accountability Office (GAO) calling on the agency to update its 2011 report entitled “Medical Devices: FDA Should Enhance Its Oversight of Recalls” in the wake of the Philips Respironics recall.
The Senators sent the letter following the Pittsburgh Post-Gazette’s and ProPublica’s reporting on the recall of certain...
Belluscura to distribute X-PLOR in Singapore
December 13, 2023HME News Staff
LONDON and PLANO, Texas – Belluscura has received approval from the Singapore Health Sciences Authority to distribute its X-PLOR portable oxygen concentrator under its exclusive licensing with InnoMax Medical Device Technology Ltd. Belluscura partnered with InnoMax in August. "We are very excited to receive this approval, enabling us to launch sales in Singapore, as a first market in the (Association of Southeast Asian Nations) region,” said CEO Bob Rauker. “With our arrangement...
Belluscura tries on DTC business
October 25, 2023HME News Staff
LONDON, PLANO, Texas, and SHENZHEN, China – Belluscura, a medical device developer focused on lightweight and portable oxygen technology, says early results on a two-month-old direct to consumer program for its X-PLOR device have exceeded initial expectations. The company has launched a three-pronged direct sales, leasing and short-term rental program for the device that has been well received by customers. "I am very excited about the new direct-to consumer sales program,” said...